Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × INDUSTRY × NET × Clear all

Phase

Phase 2 30 Phase 1 22 Phase 3 17 Phase 1/2 14 Phase 4 7 Phase NA 2 Phase 2/3 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

OTHER 16 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 31 Gastrointestinal 27 Lymphoid 26 Other hematologic neoplasm 19 Plasma cell 18 Breast 17 Thoracic 16 Head & Neck 14 Dermatologic 13 Genitourinary 12 Sarcoma 10 Gynecologic 10 CNS 8 Tumor-Agnostic 7 Other 1 NET 1 Endocrine 1 Classical hematology 1

Conditions

Neuroendocrine Tumors 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04440956 2020-06-22

An Imaging Study of 64Cu-SARTATE Using Positron Emission Tomography in Patients With Neuroendocrine Tumours

Clarity Pharmaceuticals Ltd

Phase EARLY_PHASE1 Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡